Tradestie Institutional Equity Comparison Engine

CAMP vs ZURA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CAMP Overall Edge

CAMP Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CAMP4 Therapeutics Corporation Common Stock (CAMP) driven by superior Momentum & Technical, Options & Structure while ZURA counters with relative strength in Growth & Margin. Fundamentally, CAMP trades at N/M Forward P/E with -991.8% operating margin (+138.9% YoY revenue) versus ZURA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ZURA sits in BREAKDOWN (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CAMP N/M vs ZURA N/M Fwd P/E
Growth & Margin Winner ZURA
Op Margin -991.8% vs 0.0% ยท YoY +138.9% vs +0.0%
Momentum & Technical Winner CAMP
1Y -3.7% vs -75.1% ยท 52W Pos 22% vs 1%
Options & Structure Winner CAMP
UNCLASSIFIED (N/A IV) vs BREAKDOWN (<1st %ile IV)
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$3.95
+2.33% 1D
Market Cap $238.5M
1M Return +25.8%
1Y Return -3.66%
Forward P/E N/M
Unified AI Score
43.9 / 100 HOLD
Tech 34.0 Fund 40.0 Flow 50.0 Mom 40.0
ZURA NASDAQ
Zura Bio Limited Class A Ordinary Shares
Biological Products, (No Disgnostic Substances)
$1.01
-6.02% 1D
Market Cap $119.4M
1M Return -73.36%
1Y Return -75.12%
Forward P/E N/M
Unified AI Score
46.3 / 100 HOLD
Tech 45.0 Fund 58.0 Flow 70.0 Mom 65.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CAMP -3.66% ZURA -75.12% Spread: +71.46 pp (CAMP Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CAMP TTM Op. Margin: -991.8% ZURA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CAMP vs ZURA. Trailing 12-month operating profitability (CAMP -991.8% vs ZURA 0.0%) and valuation multiples (CAMP N/M vs ZURA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CAMP (4) vs ZURA (3)
Institutional Metric CAMP ZURA Criterion Row Winner
Market Capitalization Scale $238.5M $119.4M Larger Scale CAMP
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +138.9% +0.0% Higher Growth CAMP
Operating Margin (TTM) Profitability -991.8% 0.0% Higher Margin ZURA
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -146.1% -63.2% Higher ROE ZURA
52-Week Range Position Momentum 22% ($3โ€“$8) 1% ($1โ€“$7) Stronger Trend CAMP
Beta / 30D Volatility Risk Regime 1.34ฮฒ ยท 94% Vol 0.55ฮฒ ยท 272% Vol Lower Realized Risk CAMP
Unified Institutional Score Composite Signal 43.9 / 100 (HOLD) 46.3 / 100 (HOLD) Higher Composite ZURA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CAMP vs ZURA Buy Guide
CAMP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CAMP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ZURA BREAKDOWN
59d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ZURA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CAMP nor ZURA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.